{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:15:02Z","timestamp":1791238502526,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00384-021-03968-w","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T01:50:09Z","timestamp":1623203409000},"page":"2305-2319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Visceral adiposity and inflammatory bowel disease"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2403-7436","authenticated-orcid":false,"given":"Catherine R.","family":"Rowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoibhlinn","family":"O\u2019Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"issue":"21","key":"3968_CR1","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361(21):2066\u20132078","journal-title":"N Engl J Med"},{"issue":"18","key":"3968_CR2","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMra1102942","volume":"365","author":"S Danese","year":"2011","unstructured":"Danese S, Fiocchi C (2011) Ulcerative colitis. N Engl J Med 365(18):1713\u20131725","journal-title":"N Engl J Med"},{"key":"3968_CR3","doi-asserted-by":"crossref","unstructured":"Ford AC, Moayyedi P, Hanauer SB (2013) Ulcerative colitis. Bmj 346:f432","DOI":"10.1136\/bmj.f432"},{"issue":"10114","key":"3968_CR4","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI et al (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390(10114):2769\u20132778","journal-title":"Lancet"},{"issue":"2","key":"3968_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.clnu.2016.12.027","volume":"36","author":"A Forbes","year":"2017","unstructured":"Forbes A, Escher J, H\u00e9buterne X, K\u0142\u0119k S, Krznaric Z, Schneider S et al (2017) ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr 36(2):321\u2013347","journal-title":"Clin Nutr"},{"issue":"4","key":"3968_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.cgh.2005.12.015","volume":"4","author":"DJ Hass","year":"2006","unstructured":"Hass DJ, Brensinger CM, Lewis JD, Lichtenstein GR (2006) The impact of increased body mass index on the clinical course of Crohn\u2019s disease. Clin Gastroenterol Hepatol 4(4):482\u2013488","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"3968_CR7","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/ibd.22893","volume":"18","author":"C Fink","year":"2012","unstructured":"Fink C, Karagiannides I, Bakirtzi K, Pothoulakis C (2012) Adipose tissue and inflammatory bowel disease pathogenesis. Inflamm Bowel Dis 18(8):1550\u20131557","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"3968_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/bjs.1800790934","volume":"79","author":"AL Sheehan","year":"1992","unstructured":"Sheehan AL, Warren BF, Gear MW, Shepherd NA (1992) Fat-wrapping in Crohn\u2019s disease: pathological basis and relevance to surgical practice. Br J Surg 79(9):955\u2013958","journal-title":"Br J Surg"},{"key":"3968_CR9","unstructured":"Crohn BB, Ginzburg L, Oppenheimer GD (2000) Regional ileitis: a pathologic and clinical entity. 1932. Mt Sinai J Med 67(3):263\u20138"},{"issue":"1","key":"3968_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF02553169","volume":"14","author":"FL Weakley","year":"1971","unstructured":"Weakley FL, Turnbull RB (1971) Recognition of regional ileitis in the operating room. Dis Colon Rectum 14(1):17\u201323","journal-title":"Dis Colon Rectum"},{"key":"3968_CR11","unstructured":"Association OM. Obesity Algorithm. https:\/\/obesitymedicine.org\/obesity-algorithm\/2020"},{"issue":"7","key":"3968_CR12","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1016\/j.crohns.2012.09.009","volume":"7","author":"T Nic Suibhne","year":"2013","unstructured":"Nic Suibhne T, Raftery TC, McMahon O, Walsh C, O\u2019Morain C, O\u2019Sullivan M (2013) High prevalence of overweight and obesity in adults with Crohn\u2019s disease: associations with disease and lifestyle factors. J Crohns Colitis 7(7):e241\u2013e248","journal-title":"J Crohns Colitis"},{"issue":"3","key":"3968_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/ibd\/izy278","volume":"25","author":"RV Bryant","year":"2018","unstructured":"Bryant RV, Schultz CG, Ooi S, Goess C, Costello SP, Vincent AD et al (2018) Visceral adipose tissue is associated with stricturing Crohn\u2019s disease behavior, fecal calprotectin, and quality of life. Inflamm Bowel Dis 25(3):592\u2013600","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"3968_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/apt.14293","volume":"46","author":"NS Ding","year":"2017","unstructured":"Ding NS, Malietzis G, Lung PFC, Penez L, Yip WM, Gabe S et al (2017) The body composition profile is associated with response to anti-TNF therapy in Crohn\u2019s disease and may offer an alternative dosing paradigm. Aliment Pharmacol Ther 46(9):883\u2013891","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"3968_CR15","first-page":"1306","volume":"21","author":"RW Stidham","year":"2015","unstructured":"Stidham RW, Waljee AK, Day NM, Bergmans CL, Zahn KM, Higgins PDR et al (2015) Body fat composition assessment using analytic morphomics predicts infectious complications after bowel resection in Crohn\u2019s disease. Inflamm Bowel Dis 21(6):1306\u20131313","journal-title":"Inflamm Bowel Dis"},{"key":"3968_CR16","doi-asserted-by":"publisher","first-page":"A989","DOI":"10.1016\/S0016-5085(98)84030-4","volume":"114","author":"S Hafraoui","year":"1998","unstructured":"Hafraoui S, Ernst O, Desreumaux P, Asselah T, Cortot A, Colombel JF (1998) Mesenteric obesity in Crohn\u2019s disease (CD). Gastroenterology 114:A989","journal-title":"Gastroenterology"},{"issue":"2","key":"3968_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/codi.13128","volume":"18","author":"Z Ding","year":"2016","unstructured":"Ding Z, Wu XR, Remer EM, Lian L, Stocchi L, Li Y et al (2016) Association between high visceral fat area and postoperative complications in patients with Crohn\u2019s disease following primary surgery. Colorectal Dis 18(2):163\u2013172","journal-title":"Colorectal Dis"},{"issue":"8","key":"3968_CR18","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cgh.2011.05.005","volume":"9","author":"B Erhayiem","year":"2011","unstructured":"Erhayiem B, Dhingsa R, Hawkey CJ, Subramanian V (2011) Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn\u2019s disease. Clin Gastroenterol Hepatol 9(8):684\u2013687","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3968_CR19","doi-asserted-by":"crossref","unstructured":"Holt DQ, Moore GT, Strauss BJG, Hamilton AL, De Cruz P, Kamm MA (2017)\u00a0Visceral adiposity predicts post-operative Crohn's disease recurrence. Alimentary pharmacology & therapeutics. (no pagination)","DOI":"10.1111\/apt.14018"},{"issue":"9","key":"3968_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.it.2019.07.006","volume":"40","author":"H Kane","year":"2019","unstructured":"Kane H, Lynch L (2019) Innate Immune Control of Adipose Tissue Homeostasis. Trends Immunol 40(9):857\u2013872","journal-title":"Trends Immunol"},{"issue":"6","key":"3968_CR21","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1096\/fj.03-0422fje","volume":"18","author":"S Sitaraman","year":"2004","unstructured":"Sitaraman S, Liu X, Charrier L, Gu LH, Ziegler TR, Gewirtz A et al (2004) Colonic leptin: source of a novel proinflammatory cytokine involved in IBD. FASEB journal\u202f: official publication of the Federation of American Societies for Experimental Biology 18(6):696\u2013698","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology"},{"issue":"1","key":"3968_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0016-5085(99)70552-4","volume":"117","author":"P Desreumaux","year":"1999","unstructured":"Desreumaux P, Ernst O, Geboes K, Gambiez L, Berrebi D, M\u00fcller-Alouf H et al (1999) Inflammatory alterations in mesenteric adipose tissue in Crohn\u2019s disease. Gastroenterology 117(1):73\u201381","journal-title":"Gastroenterology"},{"key":"3968_CR23","unstructured":"Project EPHP. Quality assessment tool for qualitative studies. http:\/\/www.ephppca\/tools.html. 2009."},{"key":"3968_CR24","doi-asserted-by":"crossref","unstructured":"Argeny S, Tamandl D, Scharitzer M, Stift A, Bergmann M, Riss S (2018)\u00a0Visceral fat area measured with computed tomography does not predict postoperative course in Crohn s disease patients. PLoS One 13(8):e0202220","DOI":"10.1371\/journal.pone.0202220"},{"issue":"11","key":"3968_CR25","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1097\/MIB.0000000000000527","volume":"21","author":"C Buning","year":"2015","unstructured":"Buning C, von Kraft C, Hermsdorf M, Gentz E, Wirth EK, Valentini L et al (2015) Visceral adipose tissue in patients with crohn\u2019s disease correlates with disease activity, inflammatory markers, and outcome. Inflamm Bowel Dis 21(11):2590\u20132597","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"3968_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000365359","volume":"31","author":"TM Connelly","year":"2014","unstructured":"Connelly TM, Juza RM, Sangster W, Sehgal R, Tappouni RF, Messaris E (2014) Volumetric fat ratio and not body mass index is predictive of ileocolectomy outcomes in Crohn\u2019s disease patients. Dig Surg 31(3):219\u2013224","journal-title":"Dig Surg"},{"key":"3968_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.clnesp.2017.04.005","volume":"21","author":"ML Cravo","year":"2017","unstructured":"Cravo ML, Velho S, Torres J, Costa Santos MP, Palmela C, Cruz R et al (2017) Lower skeletal muscle attenuation and high visceral fat index are associated with complicated disease in patients with Crohn\u2019s disease: An exploratory study. Clin Nutr ESPEN 21:79\u201385","journal-title":"Clin Nutr ESPEN"},{"issue":"8","key":"3968_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/1751-2980.12652","volume":"19","author":"Q Feng","year":"2018","unstructured":"Feng Q, Xu XT, Zhou Y, Yan YQ, Ran ZH, Zhu J (2018) Creeping fat in patients with ileo-colonic Crohn\u2019s disease correlates with disease activity and severity of inflammation: a preliminary study using energy spectral computed tomography. J Dig Dis 19(8):475\u2013484","journal-title":"J Dig Dis"},{"issue":"9","key":"3968_CR29","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/apt.14018","volume":"45","author":"DQ Holt","year":"2017","unstructured":"Holt DQ, Moore GT, Strauss BJ, Hamilton AL, De Cruz P, Kamm MA (2017) Visceral adiposity predicts post-operative Crohn\u2019s disease recurrence. Aliment Pharmacol Ther 45(9):1255\u20131264","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"3968_CR30","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3390\/nu10091192","volume":"10","author":"R Bryant","year":"2018","unstructured":"Bryant R, Schultz C, Ooi S, Goess C, Costello S, Vincent A et al (2018) Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of myopenia and osteopenia. Nutrients 10(9):1192","journal-title":"Nutrients"},{"issue":"3","key":"3968_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/codi.12798","volume":"17","author":"Y Li","year":"2015","unstructured":"Li Y, Zhu W, Gong J, Zhang W, Gu L, Guo Z et al (2015) Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn\u2019s disease. Colorectal Dis 17(3):225\u2013234","journal-title":"Colorectal Dis"},{"issue":"1","key":"3968_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/gastro\/gow028","volume":"5","author":"G Liu","year":"2016","unstructured":"Liu G, Wu X, Li Y, Rui Y, Stocchi L, Remzi FH et al (2016) Postoperative excessive gain in visceral adipose tissue as well as body mass index are associated with adverse outcomes of an ileal pouch. Gastroenterology report 5(1):29\u201335","journal-title":"Gastroenterology report"},{"issue":"2","key":"3968_CR33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1590\/s0004-2803.201800000-25","volume":"55","author":"DO Magro","year":"2018","unstructured":"Magro DO, Barreto MRL, Cazzo E, Camargo MG, Kotze PG, Coy CSR (2018) Visceral fat is increased in individuals with Crohn\u2019s disease: a comparative analysis with healthy controls. Arq Gastroenterol 55(2):142\u2013147","journal-title":"Arq Gastroenterol"},{"issue":"10","key":"3968_CR34","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1002\/ibd.20931","volume":"15","author":"E Parmentier-Decrucq","year":"2009","unstructured":"Parmentier-Decrucq E, Duhamel A, Ernst O, Fermont C, Louvet A, Vernier-Massouille G et al (2009) Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn\u2019s disease. Inflamm Bowel Dis 15(10):1476\u20131484","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"3968_CR35","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/DCR.0000000000001074","volume":"61","author":"W Shen","year":"2018","unstructured":"Shen W, Cao L, Li Y, Cai X, Ge Y, Zhu W (2018) Visceral fat is associated with mucosal healing of infliximab treatment in Crohn\u2019s disease. Dis Colon Rectum 61(6):706\u2013712","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"3968_CR36","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/ecco-jcc\/jjy124","volume":"12","author":"C Thiberge","year":"2018","unstructured":"Thiberge C, Charpentier C, Gillibert A, Modzelewski R, Dacher JN, Savoye G et al (2018) Lower subcutaneous or visceral adiposity assessed by abdominal computed tomography could predict adverse outcome in patients with Crohn\u2019s disease. J Crohns Colitis 12(12):1429\u20131437","journal-title":"J Crohns Colitis"},{"issue":"1","key":"3968_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MIB.0000000000000978","volume":"23","author":"KW Van Der Sloot","year":"2017","unstructured":"Van Der Sloot KW, Joshi AD, Bellavance DR, Gilpin KK, Stewart KO, Lochhead P et al (2017) Visceral adiposity, genetic susceptibility, and risk of complications among individuals with Crohn\u2019s disease. Inflamm Bowel Dis 23(1):82\u201388","journal-title":"Inflamm Bowel Dis"},{"key":"3968_CR38","doi-asserted-by":"crossref","unstructured":"Wei Y, Zhu F, Gong J, Yang J, Zhang T, Gu L et al (2018) High visceral to subcutaneous fat ratio is associated with increased postoperative inflammatory response after colorectal resection in inflammatory bowel disease. Gastroenterology research and practice\u00a02018:6270514","DOI":"10.1155\/2018\/6270514"},{"key":"3968_CR39","doi-asserted-by":"crossref","unstructured":"Yadav DP, Kedia S, Madhusudhan KS, Bopanna S, Goyal S, Jain S et al (2017)\u00a0Body composition in Crohn\u2019s disease and ulcerative colitis: correlation with disease severity and duration. Can J Gastroenterol Hepatoly.\u00a02017","DOI":"10.1155\/2017\/1215035"},{"issue":"6","key":"3968_CR40","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3390\/cells8060628","volume":"8","author":"P Eder","year":"2019","unstructured":"Eder P, Adler M, Dobrowolska A, Kamhieh-Milz J, Witowski J (2019) The role of adipose tissue in the pathogenesis and therapeutic outcomes of inflammatory bowel disease. Cells 8(6):628","journal-title":"Cells"},{"issue":"1","key":"3968_CR41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/gutjnl-2011-300391","volume":"61","author":"A Zulian","year":"2012","unstructured":"Zulian A, Cancello R, Micheletto G, Gentilini D, Gilardini L, Danelli P et al (2012) Visceral adipocytes: old actors in obesity and new protagonists in Crohn\u2019s disease? Gut 61(1):86\u201394","journal-title":"Gut"},{"key":"3968_CR42","doi-asserted-by":"crossref","unstructured":"Coope A, Pascoal LB, da Silva FAR, Botezelli JD, Ayrizono MdLS, Milanski M et al (2017)\u00a0Transcriptional and molecular pathways activated in mesenteric adipose tissue and intestinal mucosa of Crohn's disease patients. Int J\u00a0Inflam. 2017:7646859","DOI":"10.1155\/2017\/7646859"},{"issue":"2","key":"3968_CR43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/ibd\/izy201","volume":"25","author":"ED Rivera","year":"2019","unstructured":"Rivera ED, Coffey JC, Walsh D, Ehrenpreis ED (2019) The mesentery, systemic inflammation, and Crohn\u2019s disease. Inflamm Bowel Dis 25(2):226\u2013234","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"3968_CR44","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/ecco-jcc\/jjx187","volume":"12","author":"CJ Coffey","year":"2018","unstructured":"Coffey CJ, Kiernan MG, Sahebally SM, Jarrar A, Burke JP, Kiely PA et al (2018) Inclusion of the mesentery in ileocolic resection for crohn\u2019s disease is associated with reduced surgical recurrence. J Crohns Colitis 12(10):1139\u20131150","journal-title":"J Crohns Colitis"},{"key":"3968_CR45","doi-asserted-by":"crossref","unstructured":"Coffey JC, O\u2018Leary DP, Kiernan MG, Faul P (2016)\u00a0The mesentery in Crohn's disease: friend or foe? Current opinion in gastroenterology 32(4):267\u201373","DOI":"10.1097\/MOG.0000000000000280"},{"issue":"2","key":"3968_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/ecco-jcc\/jju011","volume":"9","author":"F Colombo","year":"2015","unstructured":"Colombo F, Rizzi A, Ferrari C, Frontali A, Casiraghi S, Corsi F et al (2015) Bariatric surgery in patients with inflammatory bowel disease: an accessible path? Report of a case series and review of the literature. J Crohns Colitis 9(2):185\u2013190","journal-title":"J Crohns Colitis"},{"issue":"7","key":"3968_CR47","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/ibd\/izz236","volume":"26","author":"MB Braga Neto","year":"2020","unstructured":"Braga Neto MB, Gregory MH, Ramos GP, Bazerbachi F, Bruining DH, Abu Dayyeh BK et al (2020) Impact of bariatric surgery on the long-term disease course of inflammatory bowel disease. Inflamm Bowel Dis 26(7):1089\u20131097","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"3968_CR48","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s11695-017-2595-8","volume":"27","author":"DE Magouliotis","year":"2017","unstructured":"Magouliotis DE, Tasiopoulou VS, Sioka E, Chatedaki C, Zacharoulis D (2017) Impact of bariatric surgery on metabolic and gut microbiota profile: a systematic review and meta-analysis. Obes Surg 27(5):1345\u20131357","journal-title":"Obes Surg"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-021-03968-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-021-03968-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-021-03968-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T13:47:51Z","timestamp":1633960071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-021-03968-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["3968"],"URL":"https:\/\/doi.org\/10.1007\/s00384-021-03968-w","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"30 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}